Previous reports showed that patients, following organ transplantation and being treated with inhibitors of the calcineurin/NFATc1 pathway, such as cyclosporin A and FK506, often develop osteoporosis [87, 88], suggesting that immunosuppression and anti-inflammation therapies inhibit bone formation. The gene discussed is NFATC1; the disease is osteoporosis.